British American Tobacco p.l.c. (B1TI34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 60.71 |
|---|---|
| 52-week range | 51.64 – 68.75 |
| Return, 1 month / 3 months | +6.2% / −3.2% |
| Return, 1 year / 3 years | +14.6% / +145.4% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -19.3% |
| Average daily value traded | 0.07M BRL |
| Dividend yield | 26.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
British American Tobacco is a tobacco company based in London that makes and sells cigarettes and other nicotine products. Its cigarette brands include Dunhill, Kent, Lucky Strike, Pall Mall and Rothmans, and it also offers vaping devices, tobacco heating products and oral nicotine pouches. The company serves adult consumers in many countries through distributors, retailers and its own commercial operations, and it runs research into products that carry lower health risks than smoking.
British American Tobacco p.l.c. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code B1TI34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
British American Tobacco p.l.c. (B1TI34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 60.71 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 403 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.6% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.2% | ||
| From 52-week high | -8.7% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | 9.9% | ||
| 12-month return, skipping the last month | 7.9% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.3% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 26.9% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | +6.2% |
| 3 months | −3.2% |
| 6 months | +9.9% |
| 1 year | +14.6% |
| 3 years | +145.4% |
| 5 years | +112.9% |
Signals
| 50-day / 200-day average | 57.59 / 59.98 |
|---|---|
| Golden / death cross (60 days) | Death, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jul 2026 | GBP 0.8218 |
| 25 Mar 2026 | GBP 0.7821 |
| 26 Dec 2025 | GBP 0.8176 |
| 1 Oct 2025 | GBP 0.7964 |
| 25 Jun 2025 | GBP 0.8314 |
| 26 Mar 2025 | GBP 0.8613 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.